# Watchlist

> Current holdings: [portfolio.md](portfolio.md)

Prioritized by combined signals: scanner score, insider buying, activist stakes (13D/13G), smart money holdings (13F). Last updated 2026-02-24.

- [GL](../companies/GL.md) (Globe Life) - P/E 10, ROE 21%. 5 smart money funds (Pershing Square, Third Point, Bridgewater, Citadel, DE Shaw). Scanner score 72.5.
- [CF](../companies/CF.md) (CF Industries) - 6 smart money funds. Scanner top pick (score 80.8). Fertilizer/nitrogen.
- [PFE](../companies/PFE.md) (Pfizer) - 6x activist 13D filings (10% stake, likely Starboard Value). P/E ~10, pharma defensive.
- [PRU](../companies/PRU.md) (Prudential Financial) - 17 large-holder filings (up to 45.5%), cluster of 4 insiders buying. P/E 10.4, DCF 68% upside.
- [ABT](../companies/ABT.md) (Abbott Laboratories) - 3 smart money funds + CEO bought $2M + Director $1.1M. Healthcare defensive.
- [SYF](../companies/SYF.md) (Synchrony Financial) - DE Shaw NEW position Q4 2025 + Bridgewater + Citadel. P/E 7.4, $1B/yr buybacks. 22% off 52w high.
- [EG](../companies/EG.md) (Everest Group) - Lone Pine Capital NEW massive position (biggest Q4 buy). P/E 9, ROE 11%. 4 funds. Reinsurer like ACGL but cheaper.
- [FI](../companies/FI.md) (Fiserv) - 7 funds incl. Pershing Square. P/E 10, ROE 14%. Payments/fintech.
- [SPGI](../companies/SPGI.md) (S&P Global) - Director Hubert Joly bought $1M. 4 buys / 0 sells. Monopoly moat (credit ratings duopoly). 28% off high.
- [MSFT](../companies/MSFT.md) (Microsoft) - Director bought $2M. Quality score 90.9 (highest in universe). 28% off high.
- [PAYX](../companies/PAYX.md) (Paychex) - 2 directors bought, now underwater. ROE 41%, operating margin 42%. Payroll moat. Up to 79% model upside.
- [TD](../companies/TD.md) (Toronto-Dominion Bank) - Third Point NEW position Q4. 5 funds total. P/E 11, ROE 17%.
- [JD](../companies/JD.md) (JD.com) - 4 funds (Appaloosa, Citadel, DE Shaw, Tiger Global). P/E 9, ROE 12%.
- [PDD](../companies/PDD.md) (PDD Holdings) - 3 funds. Scanner score 74.2.
- [REGN](../companies/REGN.md) (Regeneron) - Scanner score 74.2.
- [AMP](../companies/AMP.md) (Ameriprise) - Scanner score 74.4.
- [CAG](../companies/CAG.md) (Conagra Brands) - P/E 10.4, 7.3% dividend, recovering earnings.
- [NVO](../companies/NVO.md) (Novo Nordisk) - GLP-1 drugs (Ozempic/Wegovy).
- [META](../companies/META.md) (Meta) - GBM models strongly bullish (+34% to +87%). Traditional DCF says overvalued. Revenue +40%, FCF $54B.
- [NVDA](../companies/NVDA.md) (Nvidia) - GBM Opportunistic predicts +166%. Extreme valuations but ML sees AI dominance.
- [LULU](../companies/LULU.md) (Lululemon) - Premium athleisure, watch for entry ~$150.
- [BRK.B](../companies/BRK.B.md) (Berkshire Hathaway)
- [SMFG](../companies/SMFG.md) (Sumitomo Mitsui) - Improving fundamentals, rate-sensitive.
- [NE](../companies/NE.md) (Noble Corporation) - P/E 15.2, P/TBV 0.99.
- [NEM](../companies/NEM.md) (Newmont) - P/E 13.5, P/B 1.0, defensive gold.
- [HIG](../companies/HIG.md) (Hartford) - Insurance. Scanner score 71.4.
- [MRVL](../companies/MRVL.md) (Marvell) - AI/Networking silicon, high-risk 2y.
- [AMD](../companies/AMD.md) - AI accelerators + CPU share gains, high-risk 2y.

---

- [FPH](../companies/FPH.md) (Five Point Holdings) - 11/11 models bullish, avg +107.6% upside
- [ALL](../companies/ALL.md) (Allstate) - 11/11 models bullish, avg +38.4% upside
- [HAL](../companies/HAL.md) (Halliburton) - 11/12 models bullish, avg +40.5% upside
- [UPS](../companies/UPS.md) (United Parcel Service) - 13/14 models bullish, avg +36.8% upside
- [BMY](../companies/BMY.md) (Bristol-Myers Squibb)
- [CSU](../companies/CSU.md) (Constellation Software) - Software acquirer
- [QCOM](../companies/QCOM.md) (Qualcomm)
- [ASML](../companies/ASML.md) (ASML Holding) - 5 smart money funds incl. Lone Pine (new Q4)
- [ORCL](../companies/ORCL.md) (Oracle)
- [IBM](../companies/IBM.md)
- [SAP](../companies/SAP.md)
- [BIDU](../companies/BIDU.md) (Baidu)
- [CSCO](../companies/CSCO.md) (Cisco)
- [PYPL](../companies/PYPL.md) (PayPal)
- [LRCX](../companies/LRCX.md) (Lam Research) - wafer fab, memory cycle leverage
- [ZS](../companies/ZS.md) (Zscaler) - cybersecurity growth
- [SNOW](../companies/SNOW.md) (Snowflake) - data platform growth
- [COIN](../companies/COIN.md) (Coinbase) - crypto leverage, high volatility
- [PLTR](../companies/PLTR.md) (Palantir) - AI software, high valuation
- [RIO](../companies/RIO.md) - Falling income, commodity cyclical
- [MBLY](../companies/MBLY.md) (Mobileye) - Israel, Tesla competition
- [LOGI](../companies/LOGI.md) (Logitech)
- [SWKS](../companies/SWKS.md) (Skyworks)
- [MMM](../companies/MMM.md) (3M) - Industrials, lawsuit risk
- [SRFM](../companies/SRFM.md) - Hybrid airplanes

---

- [CNC](../companies/CNC.md) (Centene)
- [MU](../companies/MU.md) (Micron) - cycle looks priced in vs temporary premium model
- [EL](../companies/EL.md) (Estee Lauder) - declining margins
- [CTSH](../companies/CTSH.md) (Cognizant)
- [ARKVX](../companies/ARKVX.md) (ARK Venture Fund) - 2.90% expense ratio + illiquidity vs direct value investing
